Le Lézard
Classified in: Health
Subjects: MAV, PSF, FVT, CFG

Media Advisory - Inuit Tapiriit Kanatami and Indigenous Services Canada to Brief Media on the Tuberculosis Elimination Framework


OTTAWA, Dec. 7, 2018 /CNW/ - Please be advised that officials from Inuit Tapiriit Kanatami and Indigenous Services Canada will provide a briefing on the newly ratified Inuit Tuberculosis Elimination Framework. This Framework will guide efforts to eliminate tuberculosis among Inuit living in Inuit Nunangat by 2030.

The briefing will include a background of the Framework's development, and provide an outline of activities undertaken to prevent and treat tuberculosis in Inuit Nunangat. Following the briefing, experts from both Inuit Tapiriit Kanatami and Indigenous Services Canada will answer questions from the media.

Dial-in info and relevant documents will be shared upon request by email at [email protected]. Please note that the documents will be provided under embargo on December 9.

Date: Monday, December 10, 2018

Time: 10:00 a.m. ? 11:30 a.m. (EST)

Follow us on Twitter:

Inuit Tapiriit Kanatami
(https://twitter.com/ITK_CanadaInuit) 

GovCan ? Indigenous
(https://twitter.com/GCIndigenous)

 

SOURCE Indigenous Services Canada


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: